Meeting Logo 01 Obstacles and Opportunities on the Road to an Artificial Pancreas: Closing the Loop
Meeting Logo 02 December 19, 2005: Lister Hill Auditorium, Bethesda, MD
Home
Registration
Agenda
Local Area Info
Logistical Info
Contact
 
 
Agenda  
   
To download a PDF version of the National Library of Medicine Information Sheet, click here*.
   
To download a PDF version of this agenda, click here*.

*This PDF file requires the free Adobe Acrobat Reader for viewing.
Attention vissually impared visitors: To use common screen reading programs with PDF documents, please visit http://access.adobe.com which provides free tools that convert PDF documents to simple HTML or ASCII text.

   
7:45 a.m. - 8:15 a.m. Registration and Continental Breakfast
   
   
8:15 a.m. - 8:30 a.m. Opening Comments
  Judith Fradkin, National Institutes of Health (NIH)
  Steve Gutman, U.S. Food and Drug Administration (FDA)
   
  Lay Perspective
  Michael White, Juvenile Diabetes Research Foundation (JDRF)
  Scott Campbell, American Diabetes Association (ADA)
   
   
Optimal Targets: What Levels of Blood Glucose Should We Be Shooting For?
Chair and Discussion Leader:    Francine Kaufman, Children's Hospital Los Angeles

8:30 a.m. - 8:50 a.m. Hypoglycemia: The Barrier to Effective Insulin Therapy
  Robert Sherwin, Yale University
   
8:50 a.m. - 9:10 a.m. Possible Assays for Drug Screening
  Michael Brownlee, Albert Einstein College of Medicine
   
9:10 a.m. - 9:30 a.m. Clinical Trial Design
  Christopher Saudek, The Johns Hopkins University
   
9:30 a.m. - 10:00 a.m. Discussion
   
10:00 a.m. - 10:30 a.m. Break
   
   
Where do we Stand? The Closed Loop System
Chair and Discussion Leader:    Irl Hirsch, University of Washington

10:30 a.m. - 10:50 a.m. What is the Perfect Artificial Pancreas?: Nature's Specifications
  Richard Bergman, University of Southern California
   
10:50 a.m. - 11:10 a.m. The Fast Track To Make the Artificial Pancreas a Reality for Children With T1DM
  William Tamborlane, Yale University
   
11:10 a.m. - 11:30 a.m. Mechanical Artificial Pancreas: Current Issues and Future Directions
  Jeffrey Joseph, Thomas Jefferson University
   
11:30 a.m. - 11:50 a.m. Semi-Closed Loop Algorithms: Practical Experience
  Guido Freckmann, Institute for Diabetes Technology
   
11:50 a.m. - 12:15 p.m. Discussion
   
12:15 p.m. - 1:30 p.m. Lunch
   
   
Technical Challenges
Chair and Discussion Leader:    Bruce Buckhingham, Stanford University

1:30 p.m. - 1:50 p.m. Amperometric Glucose Sensors: Design Factors and Biological Issues
  W. Kenneth Ward, Legacy Health System
   
1:50 p.m. - 2:10 p.m. Glucose Sensor Biofouling
  Francis Moussy, University of South Florida
   
2:10 p.m. - 2:30 p.m. Algorithms for Continuous Glucose Monitoring and Control
  B. Wayne Bequette, Rensselaer Polytechnic Institute
   
2:30 p.m. - 2:50 p.m. Statistical Considerations
  William Clarke, University of Virginia
   
2:50 p.m.- 3:15 p.m. Discussion
   
3:15 p.m. - 3:45 p.m. Break
   
   
Industry Perspective: Round Table Discussion

3:45 p.m. - 4:45 p.m. Kerstin Rebrin, Abbott
  Garry Steil, Medtronic
  Jim Brauker, DexCom
  Matthias Essenprais, Roche
   
   
Regulatory Considerations: Comments and Round Table from FDA

4:45 p.m. - 5:45 p.m. Sensors
  Patricia Bernhardt
  Regulatory Path/Infusion Pumps
  Anthony Watson
  Statistics
  Marina Kondratovich
  Human Factors
  Ron Kaye
  Insulin Delivery Systems
  Shewit Bezabeh
   
5:45 p.m. Adjournment
   
   
   
Back to Top
   

 

 

 

 


Return to NIDDK Homepage.
This page last updated: 11/30/2005